New boxed warning for propylthiouracil
On April 21, the U.S. Food and Drug Administration announced the addition of a boxed warning to the label for propylthiouracil. The warning includes…
News
Ozone-depleting inhalers to be phased out
On April 13, the U.S. Food and Drug Administration announced that seven metered-dose inhalers used for asthma and chronic obstructive pulmonary disease will gradually…
FDA approves new implanted hearing system
On March 17, the U.S. Food and Drug Administration announced the approval of the Esteem, an implanted hearing system for moderate to severe sensorineural…
Counterfeit surgical mesh
On March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol brand name.…
USDA new safety requirements for beta-agonists
The U.S. Food and Drug Administration has new safety requirements for long-acting beta-agonists used to treat asthma. Read the requirements at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.,/p>
Take Note
2/11/10 Three steps to lower childhood obesity Preschool children who do one or more of the following have a lower risk for obesity, according…
The US Food and Drug Administration has approved two drugs
Morphine Sulfate Oral Solution, used to relieve moderate to severe pain in patients tolerant to opioids. liraglutide (Victoza), a once-daily injection for treating type…
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
Drugs Today – July/August 2009
A weekly update of drug news, including alerts, approvals, and removals.
Drugs Today – February 2009
WEB EXCLUSIVE! An update of drug news, including alerts, approvals, and removals.
New boxed warning for propylthiouracil
On April 21, the U.S. Food and Drug Administration announced the addition of a boxed warning to the label for propylthiouracil. The…
Ozone-depleting inhalers to be phased out
On April 13, the U.S. Food and Drug Administration announced that seven metered-dose inhalers used for asthma and chronic obstructive pulmonary disease…
FDA approves new implanted hearing system
On March 17, the U.S. Food and Drug Administration announced the approval of the Esteem, an implanted hearing system for moderate to…
Counterfeit surgical mesh
On March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol…
USDA new safety requirements for beta-agonists
The U.S. Food and Drug Administration has new safety requirements for long-acting beta-agonists used to treat asthma. Read the requirements at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.,/p>
Take Note
2/11/10 Three steps to lower childhood obesity Preschool children who do one or more of the following have a lower risk for…
The US Food and Drug Administration has approved two drugs
Morphine Sulfate Oral Solution, used to relieve moderate to severe pain in patients tolerant to opioids. liraglutide (Victoza), a once-daily injection for…
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…
Drugs Today – July/August 2009
A weekly update of drug news, including alerts, approvals, and removals.
Drugs Today – February 2009
WEB EXCLUSIVE! An update of drug news, including alerts, approvals, and removals.
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.